Yu-Kang Tu

13PUBLICATIONS
15CO-AUTHORS
Air pollution modelling and controlMolecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 13, 2023
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.

Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma

|Jan 08, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.

Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung

|Oct 10, 2022
Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.

En-Chi Hsu, Kuan-Li Wu, Ying-Ming Tsai

|Sep 14, 2022
Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.

Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu

|Jun 24, 2022
The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.

Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu

|Jun 24, 2022
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis.

Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang

Pageof 3

Frequent Collaborators

11 joint publications

Kuan-Li Wu

7 joint publications

Jen-Yu Hung

6 joint publications

Inn-Wen Chong

5 joint publications

Cheng-Hao Chuang